Skip to main content
Caplight Logo









Forsea

Forsea

Private
IsraelHealthcare & Life Scienceshttps://forseafoods.com

Last Round

Seed

Oct 26, 2022

Total Funding Raised

$5.2M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Forsea operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in October 2022.

Forsea is an agriculture and food technology company that develops cultivated seafood products using proprietary organoid technology to create sustainable alternatives to traditional fishing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Circular Economy, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Forsea Comparables

Compare Forsea with similar companies based on industry and business-model similarity.

Forsea comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wanda Fish
84%
BlueNalu
83%
Umami Bioworks
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Forsea Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 26, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Roee Nir

CEO And Co-founder

Founding Team

Moria Shimoni

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Forsea Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 38% MoM.

  • Aug 20, 2026

    Monthly visitors grew 222% MoM, reaching 3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Forsea Filings

Explore SEC and related filing metadata, where available.

Forsea filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Forsea's valuation, stock price, and market status.

Is Forsea a public or private company?

Forsea is a private company.

What is the current stock price of Forsea?

Forsea is a private company, so its shares have no public market price. Caplight tracks Forsea's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Forsea worth (valuation)?

Valuation information for Forsea is not publicly available.

Can I buy Forsea stock?

Forsea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Forsea's last funding round?

Forsea's most recent funding round was Seed on October 26, 2022.

Who are the main investors in Forsea?

Key investors in Forsea include Target Global.

Will Forsea IPO soon?

No public IPO plans have been announced for Forsea.

How can I track Forsea secondary market activity?

Caplight tracks bids, offers, and trades in Forsea's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range16
Year Founded2021
Last FundingOct 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?